Maha: ACG to invest Rs 600 crore for Asia's largest capsule plant
Mumbai: Global pharma industry supplier ACG on Tuesday said it will invest Rs 600 crore to build Asia's largest capsules manufacturing unit near Aurangabad in Maharashtra.
The facility in the backward Marathwada region will create 1,000 jobs directly and indirectly by 2023, as per a statement.
It will produce 40 billion capsules annually and will also have a research and development centre adjoining it, it said, adding that pharma and nutraceutical companies domestically and abroad will form the clients.
Officials from ACG signed a memorandum of understanding (MoU) with the Government of Maharashtra for Rs 600 crore investment in the backward Marathwada region of the state, as per the statement.
Read also: Zydus seeks DCGI approval for Desidustat to treat anaemia in kidney patients
The state government has accorded it the status of a 'mega project'.
Our vision to be a future-ready solutions provider to the pharma industry anywhere in the world and our proposed investment of approximately USD 100 million (over Rs 600 crore) in this state-of-the-art plant, is an integral part of ACG's mission to double our capsule manufacturing capacity to 240 billion capsules a year," ACG Managing Director Karan Singh said.
Read also: USFDA approves Alembic Pharma Dabigatran Etexilate Capsules
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.